Go back to Resource Center
Subcutaneously administered daclizumab (SC-DAC, humanized anti-IL-2 receptor antibody) therapy for uveitis
2003
Journal Article
Authors:
Nussenblatt, R.B.;
Rao, N.A.;
Foster, C.S.;
Sen, H.N.;
Srivastava, S.;
Ursea, R.;
Li, Z.;
Thompson, D.J.;
Peterson, J.S.;
Robinson, R.R.;
Shames, R.S.;
Buggage, R.R.
Location: Anaheim, CA
Go back to Resource Center
